Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

501
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
501
Neural Regulation01:37

Neural Regulation

39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

240
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
240
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Pharmacology And Pharmaceutical Sciences
  9. Pharmacogenomics
  11. Clinical Correlates Of Data-driven Subtypes Of Deep Gray Matter Atrophy And Dopamine Availability In Early Parkinson's Disease

Clinical correlates of data-driven subtypes of deep gray matter atrophy and dopamine availability in early Parkinson's disease

Yoonsang Oh1, Joong-Seok Kim2, Gilsoon Park3

  • 1Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

NPJ Parkinson'S Disease
|June 12, 2025

Related Experiment Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.3K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

View abstract on PubMed

Summary
This summary is machine-generated.

Machine learning identified two Parkinson's disease (PD) subtypes with distinct biomarker patterns. These subtypes show different progression rates of cardiac, motor, and cognitive symptoms, aiding personalized PD care.

Area of Science:

  • Neurodegenerative diseases
  • Biomarker discovery
  • Machine learning applications in medicine

Background:

  • Neurodegenerative diseases like Parkinson's disease (PD) exhibit significant heterogeneity.
  • Identifying distinct subtypes is crucial for understanding disease progression and developing targeted therapies.

Purpose of the Study:

  • To utilize machine learning, specifically the Subtype and Stage Inference (SuStaIn) technique, to identify data-driven subtypes of PD.
  • To compare clinical manifestations, including cardiac denervation, cognition, and motor symptoms, across identified PD subtypes.

Main Methods:

  • Applied the SuStaIn algorithm to analyze deep gray matter volume and dopamine availability data in PD patients.
  • Validated the identified subtypes using an independent external dataset.

Related Experiment Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.3K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
  • Correlated subtype characteristics with cardiac denervation, cognitive function, and motor symptoms.

    • Main Results:

    • The SuStaIn algorithm identified two distinct PD subtypes, successfully replicated in an external dataset.
    • Subtype 1: Characterized by early-onset low dopamine availability, severe cardiac denervation, and accelerated motor/cognitive decline.
    • Subtype 2: Exhibited early brain atrophy, mild cardiac denervation, and early-onset severe cognitive dysfunction, with motor and cognitive status independent of disease stage.

    Conclusions:

    • Machine learning models can effectively identify heterogeneity in PD biomarker profiles.
    • Distinct subtypes reveal potential region- and stage-specific patterns of biomarker abnormality.
    • Findings offer insights into the clinical implications of PD heterogeneity, paving the way for personalized medicine.